Ballew Advisors, Inc Gsk PLC Transaction History

Ballew Advisors, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	BUY	$42.05 - $47.77 $210 - $238	5 Added 0.04%	12,592 $506,000
Q1 2022 Apr 28, 2022	BUY	$40.23 - $47.74 $17,660 - $20,957	439 Added 3.61%	12,587 $590,000
Q4 2021 Jan 26, 2022	BUY	$38.88 - $45.31 $77 - $90	2 Added 0.02%	12,148 $552,000
Q2 2021 Jul 15, 2021	SELL	$36.52 - $41.46 $443,279 - $503,241	-12,138 Reduced 49.98%	12,146 $492,000
Q1 2021 Apr 13, 2021	BUY	$34.27 - $40.01 $416,174 - $485,881	12,144 Added 100.03%	24,284 $870,000
Q4 2020 Jan 13, 2021	BUY	$34.07 - $39.94 $4,769 - $5,591	140 Added 1.17%	12,140 $460,000
Q4 2017 Jan 30, 2018	BUY	$35.34 - $41.9 $424,080 - $502,800	12,000	12,000 $426,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Ballew Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ballew Advisors, Inc with notifications on news.